Show simple item record

dc.contributor.authorChamberlain, K.en_GB
dc.contributor.authorBaker, M.R.en_GB
dc.contributor.authorKandaswamy, P.en_GB
dc.contributor.authorShaw, E.J.en_GB
dc.contributor.authorMcVeigh, G.en_GB
dc.contributor.authorSiddiqui, F.en_GB
dc.contributor.authorRandhawa, Gurchen_GB
dc.date.accessioned2012-07-16T13:06:09Z
dc.date.available2012-07-16T13:06:09Z
dc.date.issued2012-01
dc.identifier.citationChamberlain, K., Baker, M., Kandaswamy, P., Shaw, E., McVeigh, G., Siddiqui, F. and Randhawa, G. (2012) 'Donor identification and consent for deceased organ donation: Summary of NICE guidance', British Medical Journal, 344 , pp.e341.en_GB
dc.identifier.issn0959-8138
dc.identifier.issn1468-5833
dc.identifier.doi10.1136/bmj.e341
dc.identifier.urihttp://hdl.handle.net/10547/233952
dc.description.abstractOrgan donation plays a major role in the management of patients with single organ failure of the kidneys, liver, pancreas, heart, or lung, or with combined organ failure of heart and lung (such as in cystic fibrosis) or of kidney and pancreas (such as in diabetes). A shortage of transplant organs has resulted in long waits for transplantation. Currently about 500 people in the United Kingdom die each year because of a shortage of donated organs, and at 31 March 2011 almost 7000 patients were waiting for a kidney transplant1 and would be having costly dialysis with serious morbidity and impact on quality of life. This shortage of organs is partly the result of relatively low numbers of road traffic deaths (lower than in many countries) but is also the result of inefficiencies in the donor identification and consent processes. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on improving donor identification and consent rates for deceased organ donation.
dc.language.isoenen
dc.publisherBMJen_GB
dc.relation.urlhttp://www.bmj.com/cgi/doi/10.1136/bmj.e341en_GB
dc.rightsArchived with thanks to BMJen_GB
dc.subjectartificial and donated transplantationen_GB
dc.subjectchild healthen_GB
dc.subjectend of life decisionsen_GB
dc.subjectcoma and raised intracranial pressureen_GB
dc.subjectmedical ethicsen_GB
dc.subjectgeriatric medicineen_GB
dc.subjectpalliative careen_GB
dc.subjectcranial nervesen_GB
dc.subjectepidemiologic studiesen_GB
dc.subjecthealth economicsen_GB
dc.subjecthealth policyen_GB
dc.subjecthealth service researchen_GB
dc.subjectimmunologyen_GB
dc.subjectinjuryen_GB
dc.subjectneurological injuryen_GB
dc.subjectpancreas and biliary tracten_GB
dc.subjectrenal transplantationen_GB
dc.subjecttransplantationen_GB
dc.subjecttraumaen_GB
dc.subjecturological surgeryen_GB
dc.subjectorgan donationen_GB
dc.titleDonor identification and consent for deceased organ donation: summary of NICE guidanceen
dc.typeArticleen
dc.identifier.journalBMJen_GB
html.description.abstractOrgan donation plays a major role in the management of patients with single organ failure of the kidneys, liver, pancreas, heart, or lung, or with combined organ failure of heart and lung (such as in cystic fibrosis) or of kidney and pancreas (such as in diabetes). A shortage of transplant organs has resulted in long waits for transplantation. Currently about 500 people in the United Kingdom die each year because of a shortage of donated organs, and at 31 March 2011 almost 7000 patients were waiting for a kidney transplant1 and would be having costly dialysis with serious morbidity and impact on quality of life. This shortage of organs is partly the result of relatively low numbers of road traffic deaths (lower than in many countries) but is also the result of inefficiencies in the donor identification and consent processes. This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on improving donor identification and consent rates for deceased organ donation.


This item appears in the following Collection(s)

Show simple item record